ArticleFrontiers in bioengineering and biotechnology2019

Mass Production of Highly Active NK Cells for Cancer Immunotherapy in a GMP Conform Perfusion Bioreactor.

Katharina Bröker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.